Multi-target agents
| Target Pair | Drug Name | |
|---|---|---|
| CAII --- CAI | sodium 4-chlorobenzoate | Drug Info |
| DHFR --- TYMS | 2-Amino-5-[(4-bromophenyl)sulfanyl]-6-ethylthieno[2,3-d]pyrimidin-4(3H)-one | Drug Info |
| CAII --- CAI | {3-(1H-Imidazol-4-yl)-2-[3-(4-sulfamoyl-phenyl)-thioureido]-propionylamino}-acetic acid | Drug Info |
| EGFR --- HER2 | 3-(3,4-dihydroxyphenyl)-2-(thiophene-2-carbonyl)acrylonitrile | Drug Info |
| CAII --- CAI | sodium 4-(chloromethyl)benzoate | Drug Info |
| EGFR --- Src | 3-{2-[3-(2-Methoxycarbonyl-ethyl)-1H-indol-2-yldisulfanyl]-1H-indol-3-yl}-propionic acid methyl ester | Drug Info |
| CAII --- CAI | 4-((6R,7S,8S,10R,11S,12S,14S,15R)-3,12-Di(R)-hydroxy-7-hydroxy-10,13-dimethyl-hexadecahydro-cyclopenta[a]phenanthren-17-yl)-pentanoic acid [2-(5-sulfamoyl-[1,3,4]thiadiazol-2-ylcarbamoyl)-ethyl]-amide | Drug Info |
| EGFR3 --- CSrc | 4-{2-[3-(4-carboxybenzylcarbamoyl)-1-methyl-1H-2-indolyldisulfanyl]-1-methyl-1H-3-indolylcarboxamidomethyl}benzoic acid1.5 H2O | Drug Info |
| CAII --- CAI | 2-Amino-N-[(5-chloro-2,4-disulfamoyl-phenylcarbamoyl)-methyl]-acetamide | Drug Info |
| EGFR3 --- HER2 | 1-(5-Bromo-2-hydroxybenzyl)-1-(4-fluorobenzyl)-3-phenylthiourea | Drug Info |
| CAII --- CAI | 5-(2-thienylacetamido)-1,3,4-thiadiazole-2-sulfonamide | Drug Info |
| EGFR3 --- HER2 | 2-[5-(2,2-Dicyano-vinyl)-2-hydroxy-3-methoxy-benzylsulfanyl]-benzoic acid anion | Drug Info |
| CAII --- CAI | 2,4,6-Trimethyl-1-(4-sulfamoyl-benzyloxycarbonylmethyl)-pyridinium; perchlorate | Drug Info |
| EGFR3 --- HER2 | N-[4-(4-Benzyloxy-3-chloro-phenylamino)-3-cyano-7-ethoxy-quinolin-6-yl]-2-morpholin-4-ylmethyl-acrylamide | Drug Info |
| CAII --- CAI | 2,6-Diisopropyl-4-phenyl-1-(2-sulfamoyl-benzothiazol-6-yloxycarbonylmethyl)-pyridinium; perchlorate | Drug Info |
| EGFR3 --- HER2 | 4-(1-(3-fluorobenzyl)-1H-indazol-5-ylamino)-6-aminopyrimidine-5-carbaldehyde O-benzyl oxime | Drug Info |
| CAII --- CAI | 4,5-Dichloro-6-[(7-chloro-2-oxo-2H-chromen-4-ylmethyl)-amino]-benzene-1,3-disulfonic acid diamide | Drug Info |
| EGFR3 --- HER2 | {4-(1-Benzyl-1H-indazol-5-ylamino)-5-ethyl-pyrrolo[2,1-f][1,2,4]triazin-6-yl}-carbamic acid cis-4-amino-4-methylcyclohexyl ester | Drug Info |
| CAII --- CAI | Sulfamic acid propyl ester | Drug Info |
| EGFR3 --- HER2 | 2-(4-Hydroxy-3-methoxy-5-phenylsulfanylmethyl-benzylidene)-malononitrile | Drug Info |
| CAII --- CAI | [(S)-4-Methyl-2-(4-sulfamoyl-benzoylamino)-pentanoylamino]-acetic acid | Drug Info |
| EGFR3 --- HER2 | 4-(3-bromo-2-methylphenylamino)-6,7-dimethoxyquinoline-3-carbonitrile | Drug Info |
| CAII --- CAI | 4-[3-Methyl-5-sulfamoyl-3H-[1,3,4]thiadiazol-(2E)-ylidenesulfamoyl]-benzoic acid 2-dimethylamino-1-methyl-ethyl ester | Drug Info |
| EGFR3 --- HER2 | (3R,5S)-5-((4-(1-(3-fluorobenzyl)-1H-indazol-5-ylamino)thieno[3,2-d]pyrimidin-6-yl)ethynyl)pyrrolidin-3-yl morpholine-4-carboxylate | Drug Info |
| CAII --- CAI | 4-(2-(3-nitrobenzylideneamino)ethyl)benzenesulfonamide | Drug Info |
| CAII --- CAI | {(2-{2-[2-(Bis-carboxymethyl-amino)-ethoxy]-ethoxy}-ethyl)-[(2-bromo-4-sulfamoyl-phenylcarbamoyl)-methyl]-amino}-acetic acid; compound with Zn complex | Drug Info |
| CAII --- CAI | 4-((2,4-Diaminopteridin-6-yl)methylamino)benzenesulfonic acid | Drug Info |
| CAII --- CAI | N-(2-chloro-4-sulfamoylphenyl)-2-phenylacetamide | Drug Info |
| CAII --- CAI | 2-[(1E)-{[2-(4-sulfamoylphenyl)ethyl]imino}methyl]phenyl N-[(4-chlorobenzene)sulfonyl]carbamate | Drug Info |
| CAII --- CAI | (S)-3-Methyl-2-[3-(4-sulfamoyl-phenyl)-thioureido]-butyric acid | Drug Info |
| CAII --- CAI | 4-Chloro-N-(5-mercapto-[1,3,4]thiadiazol-2-yl)-3-sulfamoyl-benzamide | Drug Info |
| CAII --- CAIX | 4-Amino-3-bromo-5-iodo-benzenesulfonamide | Drug Info |
| CAII --- CAXII | Resorcinol | Drug Info |
| CALM2 --- Cathepsin B | (1-{1-Benzyl-2-oxo-2-[(quinolin-2-ylmethyl)-carbamoyl]-ethylcarbamoyl}-3-methyl-butyl)-carbamic acid benzyl ester | Drug Info |
| CALM2 --- Cathepsin B | N-(1-Carbamoyl-2-phenyl-ethyl)-2-[2-(4-diethylaminomethyl-phenyl)-vinyl]-benzamide | Drug Info |
| CALM2 --- Cathepsin B | (S)-4-Methyl-2-[2-(naphthalene-2-sulfonyl)-ethyl]-pentanoic acid ((S)-1-formyl-3-methyl-butyl)-amide | Drug Info |
| Cathepsin K --- Cathepsin B | [(S)-1-((5S,6S)-7-Oxo-4-oxa-1-aza-bicyclo[3.2.0]hept-6-ylcarbamoyl)-2-phenyl-propyl]-carbamic acid benzyl ester | Drug Info |
| Cathepsin K --- MEP | [(S)-1-((R)-1-Phenyl-ethylaminooxalyl)-pentyl]-carbamic acid (S)-(1,2,3,4-tetrahydro-naphthalen-1-yl) ester | Drug Info |
| Cathepsin K --- MEP | {1-[4-(2-Benzyloxycarbonylamino-4-methyl-pentanoylamino)-3-oxo-azepane-1-carbonyl]-3-methyl-butyl}-carbamic acid benzyl ester | Drug Info |
| Cathepsin K --- MEP | CHEMBL563471 | Drug Info |
| Cathepsin K --- MEP | (S)-N-(3-(3-(1,3,4-oxadiazol-2-yl)phenyl)-1-(cyanomethylamino)-1-oxopropan-2-yl)benzamide | Drug Info |
| Cathepsin K --- MEP | N-(3-methyl-1-(4-(trifluoromethoxy)phenylamino)butan-2-yl)-4-morpholino-4-oxo-2-phenethylbutanamide | Drug Info |
| Cathepsin K --- MEP | 6-(4-chlorobenzyl)-7-neopentyl-7H-pyrrolo[2,3-d]pyrimidine-2-carbonitrile | Drug Info |
| Cathepsin K --- MEP | Naphthalene-1-carboxylic acid{3-methyl-1-[(S)-(S)-3-oxo-1-(pyridine-2-sulfonyl)-azepan-4-ylcarbamoyl]-butyl}-amide | Drug Info |
| Cathepsin K --- MEP | N-((S)-1-((2R,3R)-3-(benzyloxy)-1-(5-fluoroindolin-1-yl)butan-2-ylamino)-4-cyclohexyl-1-oxobutan-2-yl)-3-methoxybenzamide | Drug Info |
| CCKBR --- CCKAR | 4-[3-(4-Chloro-phenyl)-ureido]-4-dipentylcarbamoyl-butyric acid: (0.85 methanol) | Drug Info |
| CCKBR --- CCKAR | 3-{[2-(Adamantan-2-yloxycarbonylamino)-3-(1H-indol-3-yl)-2-methyl-propionyl]-phenethyl-amino}-propionic acid | Drug Info |
| CCKBR --- CCKAR | N-tert-Butyl-2-((3R,5R)-5-cyclohexyl-8-methyl-2-oxo-3-{3-[3-(1H-tetrazol-5-yl)-phenyl]-ureido}-2,3,4,5-tetrahydro-benzo[b]azepin-1-yl)-acetamide | Drug Info |
| CCKBR --- CCKAR | SID499039 | Drug Info |
| CCKBR --- CCKAR | [1-[2-(3,4-Dichloro-phenyl)-ethylcarbamoyl]-2-(1H-indol-3-yl)-1-methyl-ethyl]-carbamic acid adamantan-2-yl ester | Drug Info |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.